Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Beta-adrenergic agonist
Umeclidinium bromide/vilanterol
Другие языки:

Umeclidinium bromide/vilanterol

Подписчиков: 0, рейтинг: 0
Umeclidinium bromide/vilanterol
Umeclidinium bromide and vilanterol.svg
Umeclidinium bromide (TOP), vilanterol (BOTTOM)
Combination of
Umeclidinium bromide Muscarinic antagonist
Vilanterol Ultra-long-acting β2 agonist
Clinical data
Trade names Anoro Ellipta, Laventair Ellipta
AHFS/Drugs.com Professional Drug Facts
License data
Pregnancy
category
  • AU: B3
Routes of
administration		 Inhalation
ATC code
Legal status
Legal status
  • AU: S4 (Prescription only)
  • UK: POM (Prescription only)
  • US: ℞-only
  • EU: Rx-only
Identifiers
CAS Number
KEGG

Umeclidinium bromide/vilanterol, sold under the brand name Anoro Ellipta, among others, is a fixed-dose combination medication for the treatment of chronic obstructive pulmonary disease (COPD). It is administered by inhalation.

The most common side effects include upper respiratory tract infections (nose and throat infection), urinary tract infections (infection of the structures that carry urine), pharyngitis (inflammation of the throat), sinusitis (inflammation of the sinuses), nasopharyngitis (inflammation of the nose and throat), headache, cough, oropharyngeal pain (pain in the mouth and throat), constipation and dry mouth.

In 2020, it was the 254th most commonly prescribed medication in the United States, with more than 1 million prescriptions.



Новое сообщение